181 related articles for article (PubMed ID: 22541416)
21. Extraordinary response to omalizumab in a child with severe chronic urticaria.
Asero R; Casalone R; Iemoli E
Eur Ann Allergy Clin Immunol; 2014 Jan; 46(1):41-2. PubMed ID: 24702874
[TBL] [Abstract][Full Text] [Related]
22. Positive response to omalizumab in patients with acquired idiopathic nonhistaminergic angioedema.
Azofra J; Díaz C; Antépara I; Jaúregui I; Soriano A; Ferrer M
Ann Allergy Asthma Immunol; 2015 May; 114(5):418-9.e1. PubMed ID: 25747788
[No Abstract] [Full Text] [Related]
23. Omalizumab for chronic urticaria.
Casale TB
J Allergy Clin Immunol Pract; 2014; 2(1):118-9. PubMed ID: 24565785
[No Abstract] [Full Text] [Related]
24. Omalizumab prevents anaphylaxis and improves symptoms in systemic mastocytosis: Efficacy and safety observations.
Broesby-Olsen S; Vestergaard H; Mortz CG; Jensen B; Havelund T; Hermann AP; Siebenhaar F; Møller MB; Kristensen TK; Bindslev-Jensen C;
Allergy; 2018 Jan; 73(1):230-238. PubMed ID: 28662309
[TBL] [Abstract][Full Text] [Related]
25. Anti-IgE therapy and severe atopic dermatitis: a pediatric perspective.
Lacombe Barrios J; Bégin P; Paradis L; Hatami A; Paradis J; Des Roches A
J Am Acad Dermatol; 2013 Nov; 69(5):832-834. PubMed ID: 24124824
[No Abstract] [Full Text] [Related]
26. Biologics and the treatment of chronic rhinosinusitis.
Kern RC
J Allergy Clin Immunol; 2013 Jan; 131(1):117-8. PubMed ID: 23265697
[No Abstract] [Full Text] [Related]
27. The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticaria.
Chang TW; Chen C; Lin CJ; Metz M; Church MK; Maurer M
J Allergy Clin Immunol; 2015 Feb; 135(2):337-42. PubMed ID: 24948369
[TBL] [Abstract][Full Text] [Related]
28. JID VisualDx Quiz: January 2015.
Shabbir A; Kirsner RS
J Invest Dermatol; 2015 Jan; 135(1):1-2. PubMed ID: 25501381
[No Abstract] [Full Text] [Related]
29. Can omalizumab be effective in chronic eosinophilic pneumonia?
Domingo C; Pomares X
Chest; 2013 Jan; 143(1):274. PubMed ID: 23276861
[No Abstract] [Full Text] [Related]
30. Anti-IgE--emerging opportunities for Omalizumab.
Babu KS; Polosa R; Morjaria JB
Expert Opin Biol Ther; 2013 May; 13(5):765-77. PubMed ID: 23517576
[TBL] [Abstract][Full Text] [Related]
31. A case of allergic bronchopulmonary aspergillosis treated with omalizumab.
Sastre I; Blanco J; Mata H; García F
J Investig Allergol Clin Immunol; 2012; 22(2):145-7. PubMed ID: 22533243
[No Abstract] [Full Text] [Related]
32. Omalizumab for chronic urticaria.
Altman MC; Naimi DR
N Engl J Med; 2013 Jun; 368(26):2528-30. PubMed ID: 23802532
[No Abstract] [Full Text] [Related]
33. Omalizumab for chronic urticaria.
Benelli E; Ventura A
N Engl J Med; 2013 Jun; 368(26):2528. PubMed ID: 23802531
[No Abstract] [Full Text] [Related]
34. Omalizumab for chronic urticaria.
Wu K; Long H
N Engl J Med; 2013 Jun; 368(26):2527-8. PubMed ID: 23802530
[No Abstract] [Full Text] [Related]
35. Omalizumab for chronic urticaria.
Maurer M; Rosén K; Hsieh HJ
N Engl J Med; 2013 Jun; 368(26):2530. PubMed ID: 23802529
[No Abstract] [Full Text] [Related]
36. Omalizumab for severe atopic keratoconjunctivitis.
Taillé C; Doan S; Neukirch C; Aubier M
BMJ Case Rep; 2010 Oct; 2010():. PubMed ID: 22791726
[TBL] [Abstract][Full Text] [Related]
37. Should clinicians use omalizumab for the treatment of nasal polyps?
Naclerio RM; Baroody FM; Pinto JM
J Allergy Clin Immunol; 2013 Jul; 132(1):247. PubMed ID: 23684073
[No Abstract] [Full Text] [Related]
38. Omalizumab (Xolair) for the treatment of chronic idiopathic urticarial.
Scheinfeld N
Skinmed; 2014; 12(5):294-7. PubMed ID: 25632648
[No Abstract] [Full Text] [Related]
39. Basophil activation test: do not lose control.
Maietta G
Eur Ann Allergy Clin Immunol; 2015 Mar; 47(2):36-7. PubMed ID: 25781191
[No Abstract] [Full Text] [Related]
40. Commentary: Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria.
Sabroe RA
Br J Dermatol; 2014 Jul; 171(1):13-5. PubMed ID: 25066289
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
